The bimodal 232–243 population shift is a ratiometric readout largely immune to back-exchange, making it the most artifact-resistant sensor for weak magnetic-field effects — interleaving field-on/off in one session with an E505D artifact screen defines the envelope any biological claim must exceed.

A dual-tissue screen in bovine udder explants and human airway organoids tests whether multi-gene constellation scores outperform single markers — the strongest measurable HA-binding signal comes from an isolate retaining avian-like PB2 E627, showing receptor affinity and polymerase adaptation are decoupled.

A factorial design with WT vs ΔtnaA F. nucleatum plus PAS-B inhibitor in SNU-C4 xenografts, with the decisive falsification lever being inhibitor occupancy without transcriptional change — disambiguating drug-penetration failure from AHR-independent TERT regulation.

A prospective mother–child cohort with serial dye biomarkers, repeated testing to age 8, and shotgun microbiome profiling — VDAART precedent shows gut mediation of perinatal exposures is detectable at cohort scale, but only with ≥400 samples and species-level resolution.

A 1,000-subject validation study of AI mapping from synchronized physiological signals and blood omics to biomedical diagnoses and TCM syndromes — κ-gating syndrome labels (≥0.6) before model training matters more than architecture choice, since poor label agreement trains the model on noise.

Monodisperse 20–30 µm droplets across a 4T×3RH matrix directly link evaporation physics to PFU decay — ~66% coefficient of variation in single-cell infectious output means resolving RH non-monotonicity may require geometric-mean and nonparametric methods rather than standard t-tests.

CRISPR promoter-editing of the conserved 56-bp NR2F1 binding motif, paired with an NR2F1 allelic series — the R142L (binding abolished) vs E400* (partial binding) asymmetry offers a clean dose-response that would distinguish direct transcriptional regulation from indirect developmental disruption.

Dosa uniquely allows the same RNA that folded in vivo to be assayed under denaturing conditions — but fusion-context effects on measured phenotype remain unquantified, and a graded urea series (0–8 M) would define the harsh-condition tolerance envelope.

A 24-farm stepped-wedge trial with weekly AGI surveillance and stool pathogen panels — the stepped-wedge efficiency holds only when farm-level ICC is modest (<0.05), so high clustering from shared meals/water can erase its advantage over a parallel design.

Eighteen mesocosms (N=100 adults, M=10 introduced) genotyped across G0–G5 estimate allele-frequency trajectories, Ne, and VA(1) via temporal autocovariance — directly testing whether adding genetically diverse immigrants outperforms numerically equivalent low-diversity additions.

Ex vivo cytokine blockade (anti-IL-4/IL-13/IL-13Rα2) in aged CD8 T cells plus paired blood–tissue TCR sequencing — CD8 remodeling in aging mirrors CD8 depletion + Treg expansion in tumors, suggesting convergent cytokine-driven pathways, though the analogy remains to be causally tested.

A dual-readout assay tracking WIPI2-positive phagophore lipidation and LAMP1-positive VAIL lipidation simultaneously — the PI3P-WIPI2-ATG16L1 model competes with the newly defined ATG16L2-VAIL branch, so partitioning across an ATG16L2 expression gradient is the decisive test.

Transient tnnt2a morpholino pulses (22–34 hpf) with washout split recoverable vs committed outcomes — ligand timing is well supported but irreversibility after flow restoration is untested, and the cheap flow-pulse experiment would either establish a hard commitment boundary or reveal hematopoietic resilience.

Complementation with ΔCBM20, Δcoiled-coil, and CBM20 point-mutant LCI9 variants — current rescue data cannot yet distinguish CBM20 carbohydrate binding from scaffolding/oligomerization, and the Δcoiled-coil vs point-mutant comparison is the decisive split.

Re-training an APOE-exclusive PRS on non-European GWAS statistics and testing within-stratum calibration slopes — PRS transferability failure is a magnitude problem, not merely a direction problem, so calibration slopes are the decisive diagnostic.

A four-arm 90-day OECD TG 408 study (oat-only, oat-cultured, liquid-cultured, vehicle) plus paired LC-MS/MS metabolomics — the 2000 mg/kg NOAEL is a whole-product number, and without an oat-only arm any safety claim conflates substrate, processing artifacts, and fungal bioactives.

A pre-registered head-to-head comparing protein abundance, sequence-score, and interface-index predictions against severity ordering — G148C (29% WT level, no phenotype) vs W195R (53%, severe) shows abundance is anti-correlated with defects in at least one pair, so only a measured interface-perturbation index could win.

A three-wave design decomposing trajectory shape — SHLSET precedent shows a chronic-level effect (intercept) is statistically distinct from a slope effect, meaning MI-episodic disruption and DD-stability are separable parameters rather than competing labels for the same pathology.

Quarterly metagenomes plus annual pooled host WGS to link microbial sweeps to host allele trajectories — BGPT odds of true: 38%; the host-side statistical resolution (six pooled time points) is the weakest link, and swapping pooled WGS for 20 individually genotyped plants would more than triple causal inference power.

A 12-week randomized trial with plasma metabolite, endothelial, and platelet endpoints — TMAO's effect appears receptor-independent (chemical chaperone via IP₃/Ca²⁺), so the cleanest falsifiable signal is a within-person correlation between ΔTMAO and ΔADP-induced aggregation.

A 2×2×2 factorial with isogenic amplified/non-amplified tumor lines — NSD2 loss de-represses closed chromatin in two tissue contexts, making TE de-repression plausible but never yet tested, so the most informative single result is whether amplification status statistically interacts with NSDi for IFN induction.

A Danish registry sibling-comparison of discordant exposure across pregnancies — within-family designs are vulnerable to survivor-selection bias: restricting to mothers with ≥2 pregnancies differentially excludes exposed pregnancies that ended early, the very outcome under study.

Conditional TNFR1/2 deletion in astrocytes/perivascular cells with poly I:C challenge — the decisive control is not the cKO itself but whether TLR3-driven neurogenesis suppression survives the deletion: if it does, TNF is a bystander, not the suppressor.

Ex vivo pulse-length screens (1–72 h) and PK/PD-guided nanoparticle delivery — macaque data show IFN-α tracks disease severity rather than control, so any cure strategy must optimize for transient hit-and-exit kinetics, not sustained ISG elevation.